Varian has received FDA 510(k) clearance for its Varian Proton Therapy System, which generates protons for precision radiotherapy of lesions, tumors and conditions where radiation treatment is indicated.

The number of x-ray procedures conducted in the U.K. increased by 10 percent between 1997 and 2008, bringing the average Briton's annual exposure to radiation up from 0.33 mSv in 1997 to 0.4 mSv in 2008, a report published by the U.K. Health Protection Agency found.

Patients with no insurance or government-held insurance have worse one-year outcomes after PCI compared with those who have private insurance; however, providing universal healthcare to all may not improve outcomes, Ron Waksman, MD, told Cardiovascular Business News.

More than half of oncology administrators cite financial issues as their greatest challenge, while 95 percent say the recession has negatively impacted their work, according to a survey conducted by the American College of Oncology Administrators (ACOA).

iCAD, a developer of image analysis and workflow technologies for the identification of cancer, has completed the previously announced acquisition of Xoft, developer of the Axxent eVx electronic brachytherapy system.

McKesson, a healthcare services and IT company, has completed its acquisition of US Oncology in a total transaction, including the assumption or repayment of the outstanding debt of US Oncology and its subsidiaries, which was valued at approximately $2.2 billion.

Radiofrequency ablation (RFA) of hepatocellular carcinoma in patients with cirrhosis yielded nearly 100 percent complete responsiveness, and resulted in a five-year recurrence rate of 82 percent, according to a study published online Oct. 21 in Hepatology.

Looking back on HealthImaging.coms top viewed stories of 2010, an image begins to emerge. Like an impressionist painting, the collection offers a cursory view of the years top trends. Read on for the realists look at the year in review.